Company by this prices valued 4 mln got almost 40 mln credits. Has idea's.. Who so full... Or so trust?
Sparcks
3 tygodnie temu
OTC
Nasdaq will suspend trading of BTAI on September 8, 2026, and the company says it doesn't plan to contest the delisting. After that, the shares are expected to move to OTC Pink Limited
Thats why the price drop , i think we go down more
Sparcks
3 tygodnie temu
i dont understant anymore
who sell? why this price tank so mytch , we going to zero ?
Sparcks
3 tygodnie temu
9 oct is the date
October 9, 2026 → the deadline for submitting bids ("Qualified Bids") that can compete with Teva's offer.
October 14, 2026 → is the scheduled date for the auction, if needed. If a better offer comes in by October 9, Teva can overbid, and the other bidders can keep competing in the auction. After the auction, the result still has to be approved by the bankruptcy court, so October 14 doesn’t necessarily mean the deal will be finally closed that day.
So during this time the stock price might fluctuate , good luck all
Radar19
3 tygodnie temu
Short comment
Now company is on better situation than before Chapter 11. But price is 4 times lower. Question... How long it will be on this low level?
Radar19
3 tygodnie temu
1st target 0.24
Check last 24h.. News.. Selling assets min 57 mln
StockyMan
3 tygodnie temu
Watch this
With a predicted analyst price of 18$ someone is gonna buy this at the last minute so holding on because the drug is too good to lose so soon before approval watch this space DYOR!
pedrothecat
3 tygodnie temu
🤑
I bought 100 quid worth of shares at these levels
Give a mad man money don’t be surprised when he does some mad SH-T
Sparcks
3 tygodnie temu
ITS DONE
it's over, the bullies will sell iglamy and we will lose all our money, only a miracle will come for another buyer to offer more, a few days ago a member of the management left for another company, I think he knew what was coming, so only a miracle can save us, another buyer has to come and offer over 100 million for us to receive something, the management will receive their salaries and bonuses so for them I don't think it's too big a loss!!
$BTAI has had great success in phase 1, 2 and 3 trails.
The PDUFA decision has a target date of novemeber the 14th 2026
I expect speculative volume getting closer to the decision date.
Be aware if approved the stock could lock in some highly significant gains.
There is always risk involved if denied it could experience a heavy drop.
Good luck and safe trading👍
NFA
Sparcks
3 miesiące temu
BioXcel Therapeutics, Inc.(NasdaqCM:BTAI) added to Russell 3000E Growth Benchmark
Good news
Sparcks
4 miesiące temu
BXCL501 Shows Efficacy Across Agitation Severity in Phase 3 At-Home Trial
BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual Meeting
Ta strona może zawierać treści generowane przez społeczność, za które Trading 212 nie ponosi odpowiedzialności. Zawsze sprawdzaj informacje samodzielnie. Trading 212 świadczy usługi wyłącznie w zakresie realizacji zleceń i nie oferuje doradztwa inwestycyjnego ani zarządzania portfelem.
Budowanie bogactwa to nawyk. Zautomatyzuj to za pomocą Pie.
Inwestuj w gotowe Pies lub twórz własne, wybierając spośród tysięcy akcji i funduszy ETF.
Dowiedz się więcej
Dowiedz się więcej
Obejrzyj film
Wejdź w posiadanie nawet najdroższych akcji takich firm jak Google, Amazon i Apple
Obejrzyj film
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lizbona
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lizbona
Zobacz wszystkie instrumenty
Wsparcie 24/7
Średni czas reakcji: 29 sekund
Zacznij bogacić się już teraz
Dołącz do ponad 5 milionów użytkowników
Pobierz aplikację
Otwórz konto
Pobierz aplikację mobilną
Wszystkie przedstawione statystyki są globalne. Liczba klientów reprezentuje zasilone konta.
Doskonała
Ocena 4,6 / 5 na podstawie 103 187 recenzji na
Trustpilot
Ocena 4,6 / 5 na podstawie 103 187 recenzji na
Trustpilot
Zaproszony
Easy to understand + use
Feel confident that my money is safe and invested carefully
Zaproszony
New Account
Easy to open an account and the app is straightforward and informative
Zaproszony
My money is growing so much quicker in…
My money is growing so much quicker in this account than any other. The app is so easy to use!
Zaproszony
Ease of use for beginners and minute by…
Ease of use for beginners and minute by minute updates. Also, news bulletins are great to follow.
Zaproszony
Easy to use
Easy to use. Lots of info on stocks. I’m a beginner only trading from August 2025. And making some profits through the year.
Zaproszony
Great app!
Great app!! Simple & intuitive!!
Zaproszony
Cash ISA investment
It has been very easy to make the investment in a cash ISA and track it on the app.
Zaproszony
Really easy to use, great app
Really easy to use, transfers are super quick and the interest rate is phenomenal. Great app.
Zaproszony
The App is excellent.
The App is excellent and very secure.
Zaproszony
I like the way they keep you informed.
I like the way they keep you informed.
Zaproszony
Excellent ISA Experience
ISA Fractional shares at low cost and great app with lots of markets. My held cash gets excellent interest rate. This helps me to wait for the right moment before investing.
Best broker app by far
I’ve had an excellent experience with Trading 212. The app is exceptionally well designed, with a clean, intuitive UI that makes investing feel simple without compromising on functionality.
I particularly love features like Pies, which make it incredibly easy to build and manage a diversified portfolio, as well as the clear and well-presented performance metrics. It’s easy to understand how your investments are performing at a glance, which is something many other platforms struggle to get right.
The fees are also very competitive, making Trading 212 particularly attractive for long-term investors. The combination of low costs, excellent functionality, interests paid daily on uninvested cash and a genuinely user-friendly experience makes it the best investing platforms I’ve used.
Overall, a fantastic app that keeps adding useful features while remaining incredibly easy to use. Highly recommended for both beginners and more experienced investors.
Zaproszony
Keeping it low cost and simple
Great for both cash and stocks & shares ISA's as well as SIPP's
Zaproszony
Kept well informed on how my investment…
Kept well informed on how my investment is progressing
Zaproszony
Simple to use for someone like me
Simple to use for someone like me . Easy to add or withdraw
Zaproszony
I love it
I love it, watching the interest being added every day, being able to take money out when short abd putting as much as you can in when ever you want. I find it good to help my self be careful with money. I tell everybody how good it is.
Zaproszony
Easy to use
Easy to use, love seeing the interest increasing each day. Simple to install on iPhone, although tricky on android
Zaproszony
Good Shares ISA
Have used a zero fee competitor. Trading 212 beats them for speed of deposits and withdrawals. They also charge a lower fee for currency conversions.
Transfer in of a cash ISA was efficiently handled.
Make sure you use instant bank transfers, rather than cards or ApplePay for deposits. Cards work fine until you exceed a lifetime total deposit of £2000 (after which they have a 0.7% fee).
Zaproszony
Great for nervous newbie investors
I have been very pleasantly surprised at the good selection of ETF’s and company shares available on this platform. Armed with a little information gleaned from you tube videos I found the site simple to navigate and the purchasing tools very easy and intuitive. I can place an instruction to sell or purchase at a particular price point which I really like. I can track prices on my own investments and also monitor other potential investments. My only regret is that I didn’t sign up sooner.
Zaproszony
Great service with best initial interezt rate
Good interest rate, clear display of account status, easy to explore website, timely execution of withdrawal requests
Kilka pozytywnych recenzji naszych klientów
Nasze nagrody
Często zadawane pytania
Jaka jest cena akcji Bioxcel Therapeutics?
Aktualna cena Bioxcel Therapeutics wynosi 0,06 $.
Jaki jest 52-tygodniowy szczyt Bioxcel Therapeutics?
52-tygodniowe maksimum dla Bioxcel Therapeutics wynosi 2,96 $.
Jaki jest 52-tygodniowy poziom minimalny Bioxcel Therapeutics?
52-tygodniowe minimum dla Bioxcel Therapeutics wynosi 0,02 $.
Jaki jest tygodniowy wynik Bioxcel Therapeutics?
W ciągu ostatniego tygodnia cena Bioxcel Therapeutics zmieniła się o 28,32%.
Jaka jest miesięczna wydajność Bioxcel Therapeutics?
W ciągu ostatniego miesiąca cena Bioxcel Therapeutics zmieniła się o -93,48%.
Jaka jest 3-miesięczna wydajność Bioxcel Therapeutics?
W ciągu ostatnich trzech miesięcy cena Bioxcel Therapeutics zmieniła się o -95,13%.
Jaka jest 6-miesięczna wydajność Bioxcel Therapeutics?
W ciągu ostatnich sześciu miesięcy cena Bioxcel Therapeutics zmieniła się o -96,65%.
Jaka jest roczna wydajność Bioxcel Therapeutics?
W ciągu ostatniego roku cena Bioxcel Therapeutics zmieniła się o -98%.